Paroxysmal nocturnal hemoglobinuria: rare cause of acute renal failure by Takayasu, Vilma et al.
Article / Clinical Case Report
Artigo / Relato de Caso Clínico
61
Copyright © 2012 Autopsy and Case Reports – This is an Open Access article distributed of terms of the Creative Commons Attribution  Non-
Commercial License (http://creativecommons.org/licenses/by/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in 
any médium provided article is properly cited.
a Department of Internal Medicine – Hospital Universitário – Universidade de São Paulo, São Paulo/SP – Brazil.
Autopsy and Case Reports 2012; 2(4): 61-64
61
Paroxysmal nocturnal hemoglobinuria: rare cause of acute renal failure
Vilma Takayasua, Márcia Yoshie Kanegaea, Jairo Raysa
Takayasu V, Kanegae MY, Rays J. Paroxysmal nocturnal hemoglobinuria: rare cause of acute renal failure. Autopsy 
Case Rep [Internet]. 2012;2(4):61-64. http://dx.doi.org/10.4322/acr.2012.034
ABSTRACT
Paroxysmal nocturnal hemoglobinuria is a rare acquired disease, 
characterized by hemolytic anemia, recurrent infections, cytopenias, and 
vascular thrombosis. It occurs by non-malignant clonal expansion of one or 
more hematopoietic stem cells that acquired somatic mutations in PIG-A gene 
linked to chromosome X. This mutation results in lower erythrocyte expression 
of CD55 and CD59 surface proteins and consequently increased susceptibility 
to the complement system. The renal involvement is generally benign, resulting 
in mild impairment in urinary concentration. Acute renal failure requiring 
hemodialytic support accompanying PNH is rarely observed. The authors 
report a case of a 37-year-old male who presented with bicytopenia (hemolytic 
anemia and thrombocytopenia) associated with acute renal failure requiring 
dialysis. Diagnosis was challenging because of the rarity and unfamiliarity with 
this entity, but was confirmed by flow cytometry. In the course of the disease, 
acute pyelonephritis with multiple renal abscesses was diagnosed requiring 
prolonged antibiotic therapy. Patient outcome was favorable after the control 
of hemolysis and the infection treatment.
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CASE REPORT
A 37-year-old male patient, a farmer, born 
and resident in a small town of northeast Brazil, 
sought medical attention complaining of recurrent 
episodes of gross hematuria alternating with brownish 
urine for 5 months. This symptom worsened 2 
weeks ago, becoming continuous. Concurrently, he 
complained of asthenia, abdominal pain, nausea, 
and vomiting, which prevented him from exercising 
his daily activities. He denied the use of toxic 
substances or accidents with poisonous animals. 
The admission physical examination showed a well-
looking patient, but pale, anicteric, and afebrile; 
no edema was evidenced. Pulse rate = 80 beats 
per minute, blood pressure = 130/70 mm Hg, 
respiratory rate = 18 breaths per minute, room air 
oximetry = 97%. Cardiac, pulmonary, and abdominal 
examination was normal. The initial laboratory tests 
showed the presence of uremia (BUN = 197 mg/
dL and creatinine = 25.9 mg/dL), hyperkalemia 
(potassium = 8.6 mEq/L) with electrocardiographic 
changes,  and b icytopenia (anemia wi th 
h e m o g l o b i n  =  6 . 5  g / d L  a n d  p l a t e l e t 
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disclosed the recovery of renal function (BUN = 21 mg/
dL and creatinine = 1.2 mg/dL) allowing the removal 
of the temporary dialysis catheter. Reviewing the 
whole case the diagnosis of paroxysmal nocturnal 
hemoglobinuria (PNH) was considered. Flow cytometry 
showed a CD55 negativity in 58% of granulocytes, 
CD59 negativity in 65% of granulocytes and CD14 
negativity in 56,4% of monocytes. Red blood cells 
failed to express CD55 in 17,8% of cells and 12,3% 
of cells for CD59. Red blood cells results should be 
interpreted with caution, because the cytometry was 
undertaken after hemotransfusion. These results were 
consistent with the diagnosis of paroxysmal nocturnal 
hemoglobinuria (PNH). The patient received a packed 
red blood cells transfusion and 30 mg of prednisone 
daily aiming at hemolysis control. Joint evaluation with 
the urologist ruled out surgical intervention, opting 
for conservative treatment for 6 weeks. The patient 
presented a satisfactory outcome, weight gain, and 
fever defervescence. He was again discharged and 
was prescribed warfarin and folic acid.
DISCUSSION
PNH is a rare hemolytic anemia, caused 
by non-malignant clonal expansion of one or more 
hematopoietic stem cells that have acquired somatic 
mutations in the PIG-A gene linked to chromosome 
X. These mutations result in a defect of synthesizing 
glycosylphosphatidylinositol (GPI) anchors, and thus, 
several proteins with specific functions, typically 
anchored by GPI on the cell surface, exhibit partial 
or complete absence. Among these are the CD55 
(decay accelerating factor) and CD59 (membrane 
inhibitor of reactive lysis) that play an important role 
in regulating the activation of the complement system. 
In patients with PNH, red blood cell clone that are 
CD55 and CD59 deficient are sensitive to the action of 
complement, thus subjected to chronic intravascular 
hemolysis.1
The main clinical manifestations of PNH are 
related to abnormalities in hematopoietic function 
including hemolytic anemia, hypercoagulability, bone 
marrow aplasia or hypoplasia, and progression to 
myelodysplasia and/or acute leukemia. Recurrent 
infections are also described.1,2 Renal lesions are 
usually benign and related to chronic hemosiderin 
deposition in the renal tubules.3 The occurrence 
of acute and chronic kidney injury are observed in 
recurrent hemolysis as observed in PNH.
count = 51,600/mm3). The patient underwent 
hemodialysis, received packed blood red cells 
transfusion, and hyperkalemia was promptly treated. 
The urinary tract ultrasound was normal except for 
cortical enhanced echogenicity. Colored Doppler 
echography of the renal arteries and veins were 
normal. Proceeding the lab workup, urinalysis showed 
76,000 leukocytes/mL, 93,000 erythrocytes/mL, 
but casts were absent; 24-hours proteinuria was 
411 mg in a 2475 mL volume. Urine culture failed to 
show any bacterial growth. Serum total protein was 
5.5 g/dL, albumin 3.2 g/dL and globulins = 2.3 g/
dL. Hepatitis B antigen (HBsAg), antibodies to HIV, 
HCV and HBsAg, as well as antinuclear antibody 
(ANA) were negative; complement fractions C3 and 
C4 were normal. The search for schistocytes as well 
as direct and indirect Coombs was negative. Total 
bilirubin was normal but the lactate dehydrogenase 
was elevated (LDH = 940 U/L), reticulocytes count 
was reduced (0.3% and absolute = 8310/mm3) and 
myelogram showed slight hypercellularity with no 
atypical elements. Renal biopsy was not performed 
due to thrombocytopenia.
The patient was discharged and referred to 
chronic hemodialysis treatment and a follow up in an 
outpatient clinic.
One month later, the patient returned to the 
emergency department complaining of back pain 
and fever. Urinalysis showed marked leukocyturia 
and urine culture showed growth of more than 105 
colony-forming units of Escherichia coli, and blood 
culture was positive for the same pathogen. Diagnosis 
of acute pyelonephritis was done and ceftazidime 
was initiated and lasted 14 days. On this occasion, 
BUN = 40 mg/dL, creatinine = 3.2 mg/dL, hemoglobin 
7.7 g/dL, hematocrit = 22.8%; leukocytes = 10.100/mm3 
and platelets = 50,400/mm3. Approximately 3 days after 
the end of antimicrobial therapy, the patient presented 
with asthenia, chills, and anorexia, progressing to 
right flank pain, fever (38 ºC), and gross hematuria. 
Although he had already lost 8 kg since the very 
beginning of symptoms, the patient still presented 
well-looking, anicteric but pale. Blood pressure was 
88 × 62 mm Hg, pulse rate = 90 beats per minute, 
respiratory rate = 18 breaths per minute. Examination 
of the heart and lung remained unchanged, but 
costovertebral angle tenderness was detected on 
the right. The computed angiotomography of the 
abdomen showed signs of pyelonephritis in the right 
kidney with multiple small abscesses, homogeneous 
hepatomegaly, but no signs of renal arterial or venous 
thrombosis. New antibiotic regimen with cefepime and 
vancomycin was started. A new laboratory workup 
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impaired urinary concentration. Acute kidney injury 
with PNH patients who recovered renal function after 
a period of dialysis has been described. The renal 
biopsy of these cases shows acute tubular necrosis 
and intense deposition of hemosiderin in renal tubular 
cells. Although we have not performed a renal biopsy, 
we believe the patient had tubular injury secondary 
to massive hemolysis.3-6
Another important factor was the treatment of 
acute pyelonephritis and multiple renal abscesses. 
Recurrent infections also occur frequently in PNH and 
deserve special attention. In the case reported here, the 
infection treatment was responsible for the hemolytic 
control as well as general clinical improvement.
Regarding thrombophilia, PNH has a 
predilection for intra-abdominal venous thrombosis, 
especially the hepatic veins. In this case report, the 
renal venous and arterial thrombosis was ruled out 
as the cause of renal failure. Thromboembolism is a 
leading cause of morbidity and mortality associated 
with PNH. It is estimated that approximately 40% 
of patients with PNH submit any thrombotic event 
during life and those with a larger clone are at higher 
risk for thromboembolism. Thus, patients with PNH 
and granulocytes clone greater than 50% that do not 
have contraindications for chronic anticoagulation 
should receive warfarin for thromboembolic disease 
prophylaxis.1,7
We must consider that the only curative 
treatment available for PNH is hematopoietic stem 
cells transplantation.1,2,8 All other modalities are 
available for the control of clinical manifestations. 
Currently, transplantation is indicated only in patients 
with bone marrow failure syndromes with severe 
cytopenias because of their considerable morbidity 
and mortality. Eculizumab, another available treatment, 
is a monoclonal antibody that binds to complement 
component C5 and inhibits complement terminal 
activation.1,2,9 This treatment is indicated in selected 
patients, namely: a) those that depend on frequent 
hemo transfusion; b) those who have refractory 
symptoms (fatigue, pain, and paroxysmal intense 
and frequent target organ damage); and c) for those 
who presented with thrombosis of unknown cause, 
despite the PNH clone size. Other immunosuppressive 
schemes (cyclosporine and anti-thymocyte globulin) 
may also be considered for patients with aplastic 
anemia or myelodysplasia related to the HPN.10,11
This report illustrates a case of acute kidney 
injury primarily considered to be of unknown etiology, 
but when it is associated with hematuria, hemolytic 
The initial clinical presentation, including 
asthenia, nausea, vomiting and abdominal pain, 
was initially interpreted as resulting from anemia and 
uremia. The investigation of anemia showed elevated 
LDH compatible with hemolysis. Other findings, 
which could reinforce the diagnosis of hemolysis, 
were not present, like hyperbilirubinemia and 
reticulocytosis. Besides anemia, the patient developed 
thrombocytopenia and the reduced reticulocyte count 
pointed towards relative bone marrow failure.
Common causes of renal failure, like diabetes 
and hypertension, and other such infections (HIV, 
hepatitis B and C), systemic lupus erythematosus, 
drug toxicity, and venomous animal accidents were 
ruled out. The absence of schizocytes excluded 
the possibility of hemolytic uremic syndrome and 
thrombotic thrombocytopenic purpura. Autoimmune 
hemolytic anemia was eliminated because the 
negative result for Coombs test. Kidney biopsy was 
not undertaken because of the thrombocytopenia. 
Initially, the patient was misdiagnosed with chronic 
kidney disease of unknown etiology and treated with 
hemodialysis.
As the renal function recovered after a few 
sessions of hemodialysis, the case was reviewed. 
The association of paroxysmal reddish or brownish 
urine suggestive of hemoglobinuria, hemolytic 
anemia, abdominal pain and acute renal failure, 
raised the hypothesis of PNH, and prednisone was 
administered. Although there is no consensus on the 
use of corticosteroids in PNH, prednisone can assist 
in the reduction of hemolytic complement activation. 
Although the patient already presented a clinical picture 
compatible with PNH since the first hospitalization, 
the delay in accurate diagnosis was due to its rarity 
and the unfamiliarity with this entity.
Flow cytometry to study the expression of 
CD55 and CD59 is the choice test because of its high 
sensitivity and specificity in confirming the diagnosis 
of PNH. Ham’s test and the sucrose test, which have 
been used in the past, are currently replaced by 
cytometry.1,2
The reduction of hematopoiesis occurs in all 
patients with PNH and, in the patient of this report, was 
demonstrated by the presence of thrombocytopenia 
and reticulocytopenia.
The renal lesion is usually benign and is 
secondary to hemosiderin deposition in the proximal 
renal tubules causing mild dysfunction recognized by 
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